generalhomepagenewsPress Releasesticker Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate ─ Active Pharmaceutical Ingredient Author Bill GrubbPosted on December 3, 2021December 3, 202118353 Noramco announced today that its industry-leading cannabinoids business will become a separate company – Purisys, LLC.
